Corrigendum: Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study
- Resource Type
- Source
- Frontiers in Immunology. 14
- Subject
Immunology Immunology and Allergy - Language
- ISSN
- 1664-3224